GW Pharmaceuticals Plc ADR (GWPH)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Justin D. Gover
Employees:
496
44 1223 266800

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

GW Pharmaceuticals Plc is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel therapeutics from proprietary cannabinoid product platform in a broad range of disease areas. The company operates through the following segments: Commercial, Sativex Research & Development, and Pipeline Research & Development. The Commercial segment distributes and sells the commercial products and promotes Sativex through collaborations with pharmaceutical companies for the currently approved indication of spasticity due to multiple sclerosis. The Sativex Research & Development segment seeks to maximize the potential of Sativex through the development of new indications. The Pipeline Research & Development segment seeks to develop cannabinoid medications other than Sativex, which are using the proprietary cannabinoid technology platform. The company was founded by Geoffrey W. Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom.

Data derived from most recent annual or quarterly report
Market Cap 6.905 Billion Shares Outstanding31.534 Million Avg 30-day Volume 475.571 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS
Price to Revenue12.1631 Debt to Equity0.0 EBITDA-56.176 Million
Price to Book Value9.234 Operating Margin-11.734300000000001 Enterprise Value6.342 Billion
Current Ratio4.485 EPS Growth0 Quick Ratio3.389
1 Yr BETA 0.4796 52-week High/Low 0.0 / Profit Margin-12.4929
Operating Cash Flow Growth75.4926 Altman Z-Score20.3039 Free Cash Flow to Firm -110.121 Million
View SEC Filings from GWPH instead.

View recent insider trading info

Funds Holding GWPH (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding GWPH BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GUY GEOFFREY W DR EXECUTIVE CHAIRMAN

  • Officer
  • Director
No longer subject to file 2021-05-05 0

GRYSKA DAVID W

  • Director
No longer subject to file 2021-05-05 0

NOBLE JAMES

  • Director
No longer subject to file 2021-05-05 0

SECOR ALICIA

  • Director
No longer subject to file 2021-05-05 0

CLINE DARREN S U.S. CHIEF COMMERCIAL OFFICER

  • Officer
No longer subject to file 2021-05-05 0

MACKEY CATHERINE J

  • Director
No longer subject to file 2021-05-05 0

KNAPPERTZ VOLKER CHIEF MEDICAL OFFICER

  • Officer
No longer subject to file 2021-05-05 0

SNYDER DOUGLAS B. CHIEF LEGAL OFFICER

  • Officer
No longer subject to file 2021-05-05 0

GOVER JUSTIN D. CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
No longer subject to file 2021-05-05 0

WALDEGRAVE WILLIAM A.

  • Director
No longer subject to file 2021-05-05 0

BROWN CABOT

  • Director
No longer subject to file 2021-05-05 0

GIACOBELLO SCOTT M. CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2021-05-05 0

TOVEY CHRISTOPHER J. CHIEF OPERATING OFFICER

  • Officer
No longer subject to file 2021-05-05 0

GEORGE ADAM D. SECRETARY

  • Officer
No longer subject to file 2021-01-21 0

GANGOLLI JULIAN S PRESIDENT, NORTH AMERICA

  • Officer
No longer subject to file 2019-05-10 0

LYNCH THOMAS G

  • Director
0 2019-03-01 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
GW PHARMACEUTICALS -ADR GWPH 2021-05-05 22:15:02 UTC -0.4123 0.4623 900000
GW PHARMACEUTICALS -ADR GWPH 2021-05-05 21:45:03 UTC -0.4123 0.4623 900000
GW PHARMACEUTICALS -ADR GWPH 2021-05-05 21:15:03 UTC -0.4123 0.4623 900000
GW PHARMACEUTICALS -ADR GWPH 2021-05-05 20:45:03 UTC -0.4123 0.4623 900000
GW PHARMACEUTICALS -ADR GWPH 2021-05-05 20:15:03 UTC -0.4123 0.4623 900000
GW PHARMACEUTICALS -ADR GWPH 2021-05-05 19:45:02 UTC -0.4123 0.4623 900000
GW PHARMACEUTICALS -ADR GWPH 2021-05-05 19:15:03 UTC -0.4123 0.4623 900000
GW PHARMACEUTICALS -ADR GWPH 2021-05-05 18:45:03 UTC -0.4123 0.4623 900000
GW PHARMACEUTICALS -ADR GWPH 2021-05-05 18:15:03 UTC -0.4123 0.4623 900000
GW PHARMACEUTICALS -ADR GWPH 2021-05-05 17:45:03 UTC -0.4123 0.4623 900000
GW PHARMACEUTICALS -ADR GWPH 2021-05-05 17:15:03 UTC -0.4123 0.4623 900000
GW PHARMACEUTICALS -ADR GWPH 2021-05-05 16:45:03 UTC -0.4123 0.4623 900000
GW PHARMACEUTICALS -ADR GWPH 2021-05-05 16:15:03 UTC -0.4123 0.4623 900000
GW PHARMACEUTICALS -ADR GWPH 2021-05-05 15:45:03 UTC -0.4123 0.4623 900000
GW PHARMACEUTICALS -ADR GWPH 2021-05-05 15:15:02 UTC -0.4123 0.4623 900000
GW PHARMACEUTICALS -ADR GWPH 2021-05-05 14:45:04 UTC -0.4123 0.4623 900000
GW PHARMACEUTICALS -ADR GWPH 2021-05-05 14:15:03 UTC -0.4123 0.4623 600000
GW PHARMACEUTICALS -ADR GWPH 2021-05-05 13:45:03 UTC -0.4123 0.4623 600000
GW PHARMACEUTICALS -ADR GWPH 2021-05-05 13:15:03 UTC -0.4123 0.4623 600000
GW PHARMACEUTICALS -ADR GWPH 2021-05-05 12:45:02 UTC -0.4123 0.4623 600000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments